U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493824) titled 'Single-arm, Prospective Study of the Efficacy and Safety of Paiteling(R)Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection' on May 16, 2025.
Brief Summary: The effectiveness of Patellin (R) antibacterial solution in treating persistent cervical HR-HPV infection
Study Start Date: July 24, 2025
Study Type: INTERVENTIONAL
Condition:
Persistent HR-HPV Infection of the Cervix
Intervention:
DRUG: Patling (R) Antibacterial Liquid
Apply Patling (R) antibacterial solution locally to the cervix
Recruitment Status: RECRUITING
Sponsor: The First Hospital of Jilin University
Information provided by (Responsi...